Regional Neuronal Network Failure and Cognition in Late-Onset Sporadic Alzheimer Disease

References

1. 1.↵
   1. Papez JW

   . A proposed mechanism of emotion. Archives of Neurology and Psychiatry 1937;38:725–43

   CrossRefWeb of Science
2. 2.↵
   1. Maclean PD

   . Some psychiatric implications of physiological studies on frontotemporal portion of limbic system (visceral brain). Electroencephalogr Clin Neurophysiol 1952;4:407–18

   CrossRefPubMed
3. 3.↵
   1. Scoville WB,
   2. Milner B

   . Loss of recent memory after bilateral hippocampal lesions. J Neurol Neurosurg Psychiatry 1957;20:11–21

   FREE Full Text
4. 4.↵
   1. Aggleton JP,
   2. Brown MW

   . Episodic memory, amnesia, and the hippocampal-anterior thalamic axis. Behav Brain Sci 1999;22:425–44, discussion 444–89

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Harvey DY,
   2. Wei T,
   3. Ellmore TM,
   4. et al

   . Neuropsychological evidence for the functional role of the uncinate fasciculus in semantic control. Neuropsychologia 2013;8:00042–40
6. 6.↵
   1. Reijmer YD,
   2. Leemans A,
   3. Caeyenberghs K,
   4. et al

   . Disruption of cerebral networks and cognitive impairment in Alzheimer disease. Neurology 2013;13:13
7. 7.↵
   1. Zhou J,
   2. Greicius MD,
   3. Gennatas ED,
   4. et al

   . Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. Brain 2010;133:1352–67

   Abstract/FREE Full Text
8. 8.↵
   1. Braak H,
   2. Braak E

   . Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239–59

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Braak H,
   2. Braak E

   . Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997;18:351–57

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Thal DR,
    2. Rub U,
    3. Orantes M,
    4. et al

    . Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002;58:1791–800

    CrossRefPubMed
11. 11.↵
    1. Thal DR,
    2. Rub U,
    3. Schultz C,
    4. et al

    . Sequence of Abeta-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 2000;59:733–48

    PubMedWeb of Science
12. 12.↵
    1. Fox NC,
    2. Cousens S,
    3. Scahill R,
    4. et al

    . Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. Arch Neurol 2000;57:339–44

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Chua TC,
    2. Wen W,
    3. Slavin MJ,
    4. et al

    . Diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease: a review. Curr Opin Neurol 2008;21:83–92

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Frisoni GB,
    2. Fox NC,
    3. Jack CR Jr.,
    4. et al

    . The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 2010;6:67–77

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Herholz K

    . Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease. Expert Rev Neurother 2010;10:1667–73

    CrossRefPubMed
16. 16.↵
    1. Filippi M,
    2. Agosta F

    . Structural and functional network connectivity breakdown in Alzheimer's disease studied with magnetic resonance imaging techniques. J Alzheimers Dis 2011;24:455–74

    PubMed
17. 17.↵
    1. Bozoki AC,
    2. Korolev IO,
    3. Davis NC,
    4. et al

    . Disruption of limbic white matter pathways in mild cognitive impairment and Alzheimer's disease: a DTI/FDG-PET study. Hum Brain Mapp 2012;33:1792–802

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Villain N,
    2. Fouquet M,
    3. Baron JC,
    4. et al

    . Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease. Brain 2010;133:3301–14

    Abstract/FREE Full Text
19. 19.↵
    1. Yakushev I,
    2. Schreckenberger M,
    3. Muller MJ,
    4. et al

    . Functional implications of hippocampal degeneration in early Alzheimer's disease: a combined DTI and PET study. Eur J Nucl Med Mol Imaging 2011;38:2219–27

    CrossRefPubMed
20. 20.↵
    1. Carter SF,
    2. Caine D,
    3. Burns A,
    4. et al

    . Staging of the cognitive decline in Alzheimer's disease: insights from a detailed neuropsychological investigation of mild cognitive impairment and mild Alzheimer's disease. Int J Geriatr Psychiatry 2012;27:423–32

    PubMed
21. 21.↵
    1. Wilson RS,
    2. Leurgans SE,
    3. Boyle PA,
    4. et al

    . Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment. Arch Neurol 2011;68:351–56

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Acosta-Cabronero J,
    2. Patterson K,
    3. Fryer TD,
    4. et al

    . Atrophy, hypometabolism and white matter abnormalities in semantic dementia tell a coherent story. Brain 2011;134:2025–35

    Abstract/FREE Full Text
23. 23.↵
    1. Catani M,
    2. Thiebaut de Schotten M

    . A diffusion tensor imaging tractography atlas for virtual in vivo dissections. Cortex 2008;44:1105–32

    CrossRefPubMedWeb of Science
24. 24.↵
    1. van Velden FH,
    2. Kloet RW,
    3. van Berckel BN,
    4. et al

    . HRRT versus HR+ human brain PET studies: an interscanner test-retest study. J Nucl Med 2009;50:693–702

    Abstract/FREE Full Text
25. 25.↵
    1. McKhann G,
    2. Drachman D,
    3. Folstein M,
    4. et al

    . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939–44

    CrossRefPubMed
26. 26.↵
    1. Petersen RC

    . Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183–94

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Jones DK,
    2. Pierpaoli C

    . Contribution of cardiac pulsation to variability of tractography results. In: Proceedings of the 13th Scientific Meeting of the International Society for Magnetic Resonance in Medicine, Miami Beach, Florida. May 7–13, 2005
28. 28.↵
    1. de Jong H,
    2. van Velden FHP,
    3. Kloet RW,
    4. et al

    . Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner. Phys Med Biol 2007;52:1505–26

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Wienhard K,
    2. Schmand M,
    3. Casey ME,
    4. et al

    . The ECAT HRRT: performance and first clinical application of the new high resolution research tomograph. IEEE Trans Nucl Sci 2002;49:104–10

    CrossRef
30. 30.↵
    1. Michel C,
    2. Schmand M,
    3. Liu X,
    4. et al

    . Reconstruction strategies for the HRRT. Nuclear Science Symposium Conference Record 2000 IEEE 2000;2:14/207–15/212
31. 31.↵
    1. Byars LG,
    2. Sibomana M,
    3. Burbar Z,
    4. et al

    . Variance reduction on randoms from coincidence histograms for the HRRT. Nuclear Science Symposium Conference Record 2005 IEEE 2005;5:2622–26
32. 32.↵
    1. Watson CC

    . New, faster, image-based scatter correction for 3D PET. Nuclear Science IEEE Transactions on 2000;47:1587–94

    CrossRef
33. 33.↵
    1. Sibomana M,
    2. Byars L,
    3. Panin V,
    4. et al

    . Simultaneous measurement of transmission and emission contamination using a collimated /sup 137/Cs point source for the HRRT. Nuclear Science Symposium Conference Record 2004 IEEE 2004;4:2647–51

    CrossRef
34. 34.↵
    1. Embleton KV,
    2. Haroon HA,
    3. Morris DM,
    4. et al

    . Distortion correction for diffusion-weighted MRI tractography and fMRI in the temporal lobes. Hum Brain Mapp 2010;31:1570–87

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Smith SM,
    2. Nichols TE

    . Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 2009;44:83–98

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Stopford CL,
    2. Snowden JS,
    3. Thompson JC,
    4. et al

    . Variability in cognitive presentation of Alzheimer's disease. Cortex 2008;44:185–95

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Visser M,
    2. Jefferies E,
    3. Lambon Ralph MA

    . Semantic processing in the anterior temporal lobes: a meta-analysis of the functional neuroimaging literature. J Cogn Neurosci 2010;22:1083–94

    CrossRefPubMedWeb of Science
38. 38.↵
    1. Chetelat G,
    2. Desgranges B,
    3. Landeau B,
    4. et al

    . Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease. Brain 2008;131:60–71

    Abstract/FREE Full Text
39. 39.↵
    1. Fouquet M,
    2. Desgranges B,
    3. Landeau B,
    4. et al

    . Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease. Brain 2009;132:2058–67

    Abstract/FREE Full Text
40. 40.↵
    1. Kuczynski B,
    2. Targan E,
    3. Madison C,
    4. et al

    . White matter integrity and cortical metabolic associations in aging and dementia. Alzheimers Dement 2010;6:54–62

    CrossRefPubMed
41. 41.↵
    1. Catheline G,
    2. Periot O,
    3. Amirault M,
    4. et al

    . Distinctive alterations of the cingulum bundle during aging and Alzheimer's disease. Neurobiol Aging 2010;31:1582–92

    CrossRefPubMedWeb of Science
42. 42.↵
    1. Trojanowski JQ,
    2. Vandeerstichele H,
    3. Korecka M,
    4. et al

    . Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimers Dement 2010;6:230–38

    CrossRefPubMedWeb of Science
43. 43.↵
    1. Forster S,
    2. Grimmer T,
    3. Miederer I,
    4. et al

    . Regional expansion of hypometabolism in Alzheimer's disease follows amyloid deposition with temporal delay. Biol Psychiatry 2012;71:792–97

    CrossRefPubMedWeb of Science
44. 44.↵
    1. Selden NR,
    2. Gitelman DR,
    3. Salamon-Murayama N,
    4. et al

    . Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain 1998;121(pt 12):2249–57

    Abstract/FREE Full Text
45. 45.↵
    1. Haense C,
    2. Kalbe E,
    3. Herholz K,
    4. et al

    . Cholinergic system function and cognition in mild cognitive impairment. Neurobiol Aging 2012;33:867–77

    CrossRefPubMedWeb of Science
46. 46.↵
    1. Desgranges B,
    2. Baron JC,
    3. de la Sayette V,
    4. et al

    . The neural substrates of memory systems impairment in Alzheimer's disease: a PET study of resting brain glucose utilization. Brain 1998;121(pt 4):611–31

    Abstract/FREE Full Text
47. 47.↵
    1. Herholz K,
    2. Salmon E,
    3. Perani D,
    4. et al

    . Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 2002;17:302–16

    CrossRefPubMedWeb of Science
48. 48.↵
    1. Ishii K,
    2. Sasaki M,
    3. Yamaji S,
    4. et al

    . Relatively preserved hippocampal glucose metabolism in mild Alzheimer's disease. Dement Geriatr Cogn Disord 1998;9:317–22

    CrossRefPubMedWeb of Science
49. 49.↵
    1. Minoshima S,
    2. Giordani B,
    3. Berent S,
    4. et al

    . Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997;42:85–94

    CrossRefPubMedWeb of Science
50. 50.↵
    1. De Santi S,
    2. de Leon MJ,
    3. Rusinek H,
    4. et al

    . Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging 2001;22:529–39

    CrossRefPubMedWeb of Science
51. 51.↵
    1. Mosconi L,
    2. De Santi S,
    3. Li J,
    4. et al

    . Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiol Aging 2008;29:676–92

    CrossRefPubMedWeb of Science
52. 52.↵
    1. Mosconi L,
    2. Sorbi S,
    3. de Leon MJ,
    4. et al

    . Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J Nucl Med 2006;47:1778–86

    Abstract/FREE Full Text
53. 53.↵
    1. Mosconi L,
    2. Tsui WH,
    3. De Santi S,
    4. et al

    . Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology 2005;64:1860–67

    CrossRef
54. 54.↵
    1. Nestor PJ,
    2. Fryer TD,
    3. Smielewski P,
    4. et al

    . Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment. Ann Neurol 2003;54:343–51

    CrossRefPubMedWeb of Science
55. 55.↵
    1. Segobin SH,
    2. Matthews JC,
    3. Markiewicz PJ,
    4. et al

    . A hybrid between region-based and voxel-based methods for partial volume correction in PET. Nuclear Science Symposium Conference Record (NSS/MIC) 2010 IEEE 2010;3073–78
56. 56.↵
    1. Gutierrez D,
    2. Montandon M-L,
    3. Assal F,
    4. et al

    . Anatomically guided voxel-based partial volume effect correction in brain PET: impact of MRI segmentation. Comput Med Imaging Graph 2012;36:610–19

    CrossRefPubMed
57. 57.↵
    1. Ashburner J,
    2. Friston KJ

    . Unified segmentation. Neuroimage 2005;26:839–51

    CrossRefPubMedWeb of Science
58. 58.↵
    1. Ashburner J

    . A fast diffeomorphic image registration algorithm. Neuroimage 2007;38:95–113

    CrossRefPubMedWeb of Science
59. 59.↵
    1. Smith SM,
    2. Jenkinson M,
    3. Johansen-Berg H,
    4. et al

    . Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006;31:1487–1505

    CrossRefPubMedWeb of Science
60. 60.↵
    1. Smith SM,
    2. Johansen-Berg H,
    3. Jenkinson M,
    4. et al

    . Acquisition and voxelwise analysis of multi-subject diffusion data with tract-based spatial statistics. Nat Protoc 2007;2:499–503

    CrossRefPubMedWeb of Science
61. 61.↵
    1. Hammers A,
    2. Allom R,
    3. Koepp MJ,
    4. et al

    . Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp 2003;19:224–47

    CrossRefPubMedWeb of Science
62. 62.↵
    1. Hua K,
    2. Zhang J,
    3. Wakana S,
    4. et al

    . Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. Neuroimage 2008;39:336–47

    CrossRefPubMedWeb of Science